高分辨率CT、18F-FDG与18F-NaF PET成像用于动脉粥样硬化纵向监测的临床前评估
研究以ApoE缺陷小鼠高胆固醇饮食12–20周诱导钙化性动脉粥样硬化,设野生型C57BL/6对照,在12、15、18、20周行18F-NaF microPET/CT、18F-FDG PET/CT及高分辨率microCT,并取主动脉做组织学验证。结果显示18F-NaF PET较microCT更早检出钙化,18F-NaF信号在18周达峰,而CT信号随15、18、20周分别增至13、16、29倍;18F-FDG在早期有差异但随疾病进展显著降低。作者认为18F-NaF与18F-FDG PET对早期病变敏感,18F-NaF PET与高分辨率microCT适于监测晚期进展性疾病。
要点
- 18F-NaF PET在同一个队列中检出动脉粥样硬化钙化早于microCT。
- ApoE缺陷小鼠18F-NaF信号较野生型高约6倍,且信号在18周达峰。
- 18F-FDG在12、15周5小时显像时ApoE缺陷组高于野生型,但随疾病进展显著降低。
核心结论
- 18F-NaF PET与18F-FDG PET是早期检出动脉粥样硬化病变的敏感影像方法,而18F-NaF PET与高分辨率microCT对监测晚期及进展性疾病有效。
研究设计与样本
- 6周龄雄性ApoE缺陷小鼠(Apoe-/-)给予高胆固醇饮食12–20周诱导钙化性动脉粥样硬化,年龄匹配雄性野生型C57BL/6小鼠以常规饲料喂养作为对照组。
- 在开始各自饮食后12、15、18、20周进行显像,18F-NaF microPET/CT于静脉注射后1小时和3小时采集,另一队列18F-FDG PET/CT于注射后3小时和5小时采集,所有小鼠均采集高分辨率microCT。
- 每次显像后每组取一个亚组(n=3)处死行主动脉组织学分析以确认疾病进展。
主要发现
- 在同一个队列中,18F-NaF PET检出动脉粥样硬化钙化早于microCT。
- 注射后1小时和3小时,ApoE缺陷小鼠的钙化病变信号均较野生型高6倍。
- 18F-NaF信号在18周达峰,而主动脉CT信号在15、18、20周分别增至13倍、16倍、29倍。
- 12周和15周时,注射后5小时采集的图像中ApoE缺陷小鼠的18F-FDG主动脉摄取显著高于野生型对照,而注射后3小时采集时无此差异。
- 在炎症显著升高的≥16周,18F-FDG在ApoE缺陷与野生型对照间相当,且随疾病进展显著降低,与组织学分析相反。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
RATIONALE: Detection of atherosclerosis is essential to the management and prevention of life-threatening cardiovascular events. Although non-invasive imaging modalities, such as 18F-sodium fluoride (18F-NaF), 18F-fluorodeoxyglucose (18F-FDG) PET, and CT, visualize distinct hallmarks of atherosclerosis, there has yet to be a singular multi-cohort interrogation of their strengths and limitations. Thus, we focused on identifying the optimal approach for visualizing atherosclerosis at different stages of disease progression. METHODS: In this study, 6-week-old, male, ApoE deficient mice (Apoe-/-) were placed on a high cholesterol diet for 12-20 weeks to induce calcific atherosclerotic disease. Age-matched, male, wildtype (WT) C57BL/6 mice fed with regular chow served as the control group. Mice were imaged at 12, 15, 18, and 20 weeks after starting their respective diets. To follow the progression of calcified atherosclerotic lesions, at each time point, in vivo, 18F-NaF microPET/CT images were acquired 1 h and 3 h post tracer i.v. injection. In a separate cohort, in vivo 18F-FDG PET/CT images were acquired at 3 and 5 h post tracer i.v. injection to follow inflammation as a result of progressive atherosclerotic lesion formation. High-resolution microCT images were acquired for all mice to visualize aorta calcification. After each imaging session, a subset (n = 3) was euthanized from each group and histological analysis of the aorta was performed to confirm disease progression. RESULTS: In this comparative study, within the same cohort, 18F-NaF PET detected atherosclerotic calcification earlier than microCT. At both 1 and 3 h post-injection (p.i.), calcified lesions were clearly detected by 18F-NaF with a six-fold higher signal in Apoe-/- compared to WT mice. Interestingly, 18F-NaF signal peaked at week 18, whereas aortic CT signal progressively increased with a 13-, 16-, and 29-fold at 15, 18, and 20 weeks, respectively. 18F-FDG arortic accumulation at weeks 12 and 15, were significantly greater in Apoe -/- mice than WT control when images were acquired at 5 h but not at 3 h p.i.. In contrast to histological analysis, at ≥ 16 weeks where inflammation is significantly elevated, 18F-FDG was equivalent in Apoe-/- and WT control mice and significantly reduced with disease progression. CONCLUSIONS: Our results show that 18F-NaF PET and 18F-FDG PET are sensitive imaging modalities for the early detection of atherosclerotic lesions. However, both 18F-NaF PET and high-resolution microCT prove to be effective methods for monitoring late-stage and progressive disease.
引用
- Tamboline M, Collins J, Jackson W, et al. Preclinical evaluation of high-resolution CT, 18F-FDG, and 18F-NaF PET imaging for longitudinal monitoring of atherosclerosis. Eur J Nucl Med Mol Imaging. 2025. PMID: 40289041. doi:10.1007/s00259-025-07276-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。